Scientific Advisors

Bruce S. Bochner, MD


Dr. Bochner is a co-founder of Allakos and has been a member of its Scientific Advisory Board since 2012.

Dr. Bochner is a physician-scientist and co-discoverer of Siglec-8. His ongoing NIH-funded research work focuses on the glycobiology and function of Siglec-8 and related inhibitory receptors on cells of the immune system. He is the author of more than 295 peer-reviewed publications, reviews, and book chapters, with an interest in the mechanisms of allergic cell recruitment, activation and survival in human allergic inflammatory responses. Dr. Bochner is a Fellow of the American Academy of Allergy, Asthma, and Immunology, and a member of the Omega Alpha Omega Medical Honors Society, the American Society for Clinical Investigation, and the Association of American Physicians. He is the Immediate Past President of the International Eosinophil Society and the current President of the Collegium Internationale Allergologicum. He previously served on the Board of Directors of the American Board of Allergy and Immunology and the Board of Directors for the American Academy of Allergy, Asthma, and Immunology. He is co-Editor-in-Chief for the Allergy and Immunology Section of the online resource UpToDate and was a co-editor of the Middleton’s Allergy: Principles and Practice textbook. Prior to his current position, he was Professor of Medicine in the Division of Allergy and Clinical Immunology and a Cosner Scholar in Translational Research at the Johns Hopkins University School of Medicine and was Division Director from 2003-2013.

Dr. Bochner received a Bachelor of Arts degree with honors in Natural Sciences from the Johns Hopkins University in Baltimore, Maryland and attended medical school at the University of Illinois College of Medicine in Chicago, where he again graduated with honors. He is board-certified in both Internal Medicine and Allergy and Immunology.

Robert Schleimer, PhD


Dr. Schleimer is a co-founder of Allakos and has been a member of its Scientific Advisory Board since 2012.

Dr. Schleimer is an expert in the molecular mechanisms of allergic disease, focusing on inflammation, innate and adaptive immunity and is a co-discoverer of Siglec-8. Dr. Schleimer has published over 400 papers and was recognized as one of the most highly cited researchers worldwide by The Institute for Scientific Information (ISI). Dr. Schleimer has served on numerous boards and review committees for the NIH and on dozens of scientific and medical advisory boards for pharma, biotech and startup companies. He has also been on the editorial board of numerous medical journals relevant to Allergy and Immunology. Prior to his current position at Northwestern, Dr. Schleimer was Professor of Medicine at the Johns Hopkins University School of Medicine in the Division of Allergy and Clinical Immunology. Dr. Schleimer’s laboratory has had continuous funding from the NIH for over 35 years. Dr. Schleimer majored in Biology at The University of California at San Diego and received a PhD in Pharmacology and Toxicology at University of California at Davis.